Management of a Primary Retroperitoneal Yolk Sac Tumor.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
27 Oct 2021
Historique:
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 30 10 2021
Statut: epublish

Résumé

BACKGROUND Existing literature has detailed occurrences of retroperitoneal yolk sac tumors (YSTs) as the result of metastasis from a primary gonadal site. However, primary retroperitoneal YSTs are extremely rare, thus remaining a challenge to diagnose and treat. We present a complex case of a large primary retroperitoneal YST in a man treated with neoadjuvant chemotherapy followed by surgical resection. CASE REPORT A 31-year-old man presented with a chief symptom of severe lower abdominal pain. Diagnostic imaging revealed a large, rapidly progressing neoplasm in the retroperitoneal region, initially thought to be a sarcoma. However, the pathological results from further biopsies found the mass to be a retroperitoneal YST, which was tethered to a large portion of the small bowel. A testicular ultrasound was used to confirm that the mass was a primary tumor with no origins in the gonads. The tumor progressed to involve several fistulas connected to the small intestine and anterior abdominal wall. The patient was treated with 3 cycles of bleomycin, etoposide, and cisplatin, followed by surgical excision of the residual mass. The patient retained normal gastrointestinal functions, and subsequent imaging revealed no evidence of recurrence 2.5 years following resection. CONCLUSIONS Owing to the rarity of extragonadal primary YSTs, diagnostic and treatment standards have not yet been sufficiently explored. Our case demonstrates that a combination of chemotherapy and surgical resection should be considered for select patients with primary YST in the retroperitoneal region.

Identifiants

pubmed: 34705815
pii: 933258
doi: 10.12659/AJCR.933258
pmc: PMC8557854
doi:

Substances chimiques

Etoposide 6PLQ3CP4P3
Cisplatin Q20Q21Q62J

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e933258

Références

Pediatr Neurosurg. 1996;24(5):242-51
pubmed: 8933567
Contemp Oncol (Pozn). 2013;17(6):530-2
pubmed: 24592142
Int J Androl. 2012 Aug;35(4):616-25
pubmed: 22320869
Cancer Med. 2019 Nov;8(16):6832-6840
pubmed: 31568647
J Clin Oncol. 2002 Apr 1;20(7):1864-73
pubmed: 11919246
J Clin Oncol. 2001 Mar 15;19(6):1641-8
pubmed: 11250992
Scand J Urol Nephrol. 2001 Dec;35(6):515-7
pubmed: 11848434
Am J Surg Pathol. 2006 Jul;30(7):858-65
pubmed: 16819328
Cancer Res. 2000 Mar 15;60(6):1475-82
pubmed: 10749107
Adv Anat Pathol. 2007 Mar;14(2):69-92
pubmed: 17471115
Oncol Lett. 2014 Aug;8(2):556-560
pubmed: 25009643
Int J Gynecol Cancer. 2018 May;28(4):713-720
pubmed: 29461339
J Urol. 1996 Jul;156(1):85-8
pubmed: 8648846
Cancer. 1981 Jan 1;47(1):19-21
pubmed: 6161688

Auteurs

Mira Shoukry (M)

Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.

Jamie L Kaplan (JL)

Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.

Catherine A Mangum (CA)

Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.

Sanjay Bagaria (S)

Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.

Emmanuel Gabriel (E)

Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH